Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Fooladi AA et al. – The data suggest that MPL is a suitable adjuvant that probably leads to more sustained effect of SEB. Because the results of our cytokine assay indicate that the level of IFN–g compared with IL–4, SEB + MPL could be a candidate for tumor therapy.


   

Today in Basic Science/Genetics...keeping you current

Advances in fibromyalgia treatment: understanding endogenous pain modulation
International Journal of Clinical Rheumatology, 11/09/09

How triggers trigger acute migraine attacks: A hypothesis
Medical Hypotheses, 11/23/09

Functional activation of proline-rich tyrosine kinase2 (PYK2) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
BMC Musculoskeletal Disorders, 11/18/09

Today in Infectious Disease...keeping you current

HIV-Specific Health Care Utilization and Mortality among Tuberculosis/HIV Coinfected Persons
AIDS Patient Care and STDs, 10/06/09

Influenza Management Guide 2009-2010
American Family Physician, 11/18/09

Acyclovir: a new use for an old drug
Current Opinion in Infectious Diseases, 10/28/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address